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Background: Takotsubo syndrome (TTS) is characterized by a transient left and/or right ventricular dysfunction as a
consequence of a distinctive pattern of regional wall motion abnormalities. However, a systematic evaluation of the
left atrial (LA) function in patients with TTS is lacking. The aim of the present study was therefore to
comprehensively assess LA performance indexes and function in patients with TTS.
Methods: We compared LA function assessed by volumetric indexes derived from fractional volume changes in
cardiovascular magnetic resonance (CMR) between 125 TTS patients and 125 patients with anterior ST-segment
elevation myocardial infarction (STEMI). Furthermore, recovery of LA performance was evaluated in a subgroup of
20 TTS patients with follow-up CMR data.
Results: Patients with TTS demonstrated a significantly lower total LA emptying fraction (EF) [44% (interquartile
range (IQR) 34–53%) versus 51% (IQR 42–56%); p < 0.01], passive LA-EF [21% (IQR 14–30%) versus 24% (IQR 20–29%);
p = 0.03] and active LA-EF [29% (IQR 20–38%) versus 35% (28–42%); p < 0.01] compared to patients with anterior
STEMI. Among the 20 TTS patients with serial CMR data, the total LA-EF significantly improved from 42% (IQR
29–48%) at the acute stage to 51% (IQR 46–59%) at follow-up (p < 0.01). Similarly, active LA-EF (p < 0.01) and
passive LA-EF (p = 0.02) improved significantly as well.
Conclusion: Compared to anterior STEMI, TTS patients demonstrated a significantly decreased LA function
during the acute/subacute phase of the disease. However, impairment of LA performance seems to be
transient in TTS with recovery during follow-up.
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The left atrium plays a key role in the cardiac cycle by
modulating left ventricular (LV) filling and performance.
Left atrial (LA) function is complex and comprises 3
basic aspects: (a) a reservoir function for pulmonary ven-
ous return during ventricular systole; (b) a conduit func-
tion (passive emptying) during early ventricular diastole;
and (c) a booster pump function (active contraction when
sinus rhythm is present) to enhance ventricular filling dur-
ing late ventricular diastole [1]. Structural and functional* Correspondence: ingo.eitel@uskh.de; ingo.eitel@uksh.de
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pact have been described in a wide range of cardiovascular
diseases including atrial fibrillation, heart failure, chronic
hypertension, and acute myocardial infarction [2–6].
Patients with Takotsubo syndrome (TTS) exhibit a
peculiar pattern of regional hypokinesis, akinesis, or
dyskinesis affecting the apical and/or midventricular or
basal segments of the left ventricle [7, 8]. Furthermore,
right ventricular involvement has been reported in about
one-third of TTS patients [8]. These wall motion abnor-
malities cause a transient impairment of ventricular
function which recovers completely within several weeks
[7, 8]. Despite intensive research efforts the pathophysi-
ology of the disease has still not been fully elucidated,
yet. Similarly, the reason for the local distribution of
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be ruled out that TTS directly impacts LA performance
as well. Moreover, a secondary deterioration of LA func-
tion due to the severe LV contraction disturbances seems
possible given the complex interplay between the left
ventricle and atrium. Recently, a small study reported
decreased passive LA emptying volumes in a small co-
hort of TTS patients [9]. However, a systematic evalu-
ation of LA function in a large TTS population has not
been performed to date.
The aim of the present study was to comprehensively
assess LA function in a cohort of consecutive patients
with TTS by using cardiovascular magnetic resonance
(CMR), the reference standard for measurements of
cardiac chamber volumes and function [10]. Moreover,
the observed values were compared with a control popu-
lation consisting of patients with acute anterior ST-
segment elevation myocardial infarction (STEMI), a
major differential diagnosis of TTS [11].
Methods
Study population
A total of 178 consecutive patients were diagnosed with
TTS at the University of Leipzig – Heart Center between
January 2005 and December 2013. Of these, CMR
imaging was not performed in 53 patients due to the
following reasons: cardiogenic shock/death (n = 19), me-
tallic implants (n = 18), claustrophobia/no informed
consent (n = 11), and organizational error (n = 5). The
remaining 125 patients underwent CMR imaging for
diagnosis confirmation and comprised the TTS popula-
tion in the present study. All patients presented with
acute chest pain and/or dyspnea and fulfilled the Mayo
Clinic criteria: (a) transient hypokinesis, akinesis, or dys-
kinesis of the LV apical and/or midventricular or basal
segments extending beyond a single epicardial vascular
distribution; (b) absence of significant obstructive coron-
ary artery disease or angiographic evidence of acute
plaque rupture; (c) new electrocardiographic abnormal-
ities (either ST-segment elevation and/or T-wave inver-
sion) or modest elevation in cardiac troponin levels; and
(d) absence of pheochromocytoma and myocarditis [8].
Complete recovery of LV dysfunction was documented
in all patients within 6 months after initial presentation
using transthoracic echocardiography. In addition, 20 of
the 125 patients underwent follow-up CMR based on
individual decisions by the treating physicians.
The control group consisted of 125 patients with an-
terior STEMI who participated in the CMR substudy of
the “Abciximab Intracoronary versus intravenous Drug
Application in STEMI (AIDA STEMI)” trial [12, 13].
The CMR substudy was conducted at 8 sites in Germany
with proven experience in performing CMR examina-
tions and included 795 patients [13]. STEMI diagnosisrequired the presence of ST-segment elevation ≥0.1 mV
in ≥2 limb leads or ≥0.2 mV in ≥2 precordial leads in
the electrocardiogram. Only patients with anterior in-
farction (defined as culprit lesion in the left anterior
descending coronary artery) were considered eligible.
The control population was chosen randomly from a list
of eligible patients by personnel otherwise not involved
in the study.
The study was approved by the local ethics committee
and complied with the principles of the Helsinki Declar-
ation. All patients provided written informed consent.
CMR
CMR was performed within 10 days after the initial
event on a 1.5- or 3.0-T magnetic resonance scanner in
all patients. The standard imaging protocols for patients
with myocardial infarction and suspected TTS have been
used in several trials and included ECG-gated balanced
steady state–free precession sequences in long-axis 2-
and 4-chamber views [7, 13–15]. The imaging protocols
and sequence parameters were identical in all patients.
A post-hoc analysis was performed offline with certified
CMR evaluation software (cmr42, Circle Cardiovascular
Imaging Inc, Calgary, Alberta, Canada). LA function was
assessed by using volumetric indexes derived from frac-
tional volume changes as described previously [2–4, 10].
LA area was tracked manually in 2- and 4-chamber
views excluding LA appendage and pulmonary veins to
calculate LA volumes according to the biplane area-
length method [16]. LA volumes were determined at
ventricular end-systole (maximal LA volume, LAmax), at
ventricular diastole immediately before atrial contraction
(LApre-A), and at late ventricular diastole after atrial con-
traction (minimal LA volume, LAmin) (Fig. 1). Total
emptying fraction (EF, corresponding to global LA func-
tion and reservoir function), passive EF (corresponding
to LA conduit function), and active EF (corresponding
to LA booster pump function) were calculated according
to the following equations [1, 10]:
Total EF ¼ LAmax−LAminð Þ  100
LAmax
Passive EF ¼ LAmax−LApre−A
  100
LAmax
Active EF ¼ LApre−A−LAmin
  100
LApre−A
All analyses were performed by blinded, experienced
investigators. The core laboratory has proven low in-
ter- and intraobserver variability and excellent repro-
ducibility [17].
Fig. 1 Measurement of left atrial volumes. LA area was tracked in 4-chamber (Panels a-c) and 2-chamber views (Panels d-f) for biplane assessment
of LA volumes at ventricular end-systole (Panels a and d), immediately before atrial contraction (Panel b and e) as well as at ventricular end-
diastole (Panels c and f). The example shows a TTS patient with typical apical ballooning (blue arrows)
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Categorical variables are presented as frequencies and
percentages and were compared with the Chi square
test. Continuous data are reported as mean ± standard
deviation in case of normal distribution or as median
with interquartile range (IQR) for non-normally distrib-
uted variables. Testing for differences was performed
with the Student’s t test or the Mann-Whitney U test,
respectively. The Shapiro-Wilk test was used to test for
normal distribution.
Among patients with TTS, LA function was compared
between patients with typical apical ballooning and pa-
tients with atypical ballooning patterns (defined as
midventricular or basal ballooning) as well as between
patients with ongoing LV dysfunction and those with
already recovered contraction (defined as LV ejection
fraction >55%). Correlation between LV and LA function
was analyzed with the Pearson method. The Wilcoxon
signed-rank test was used to compare the total LA-EF
within the cohort of patients with follow-up CMR data.
Statistical analyses were performed with SPSS (version
17.0; SPSS Inc.; Chicago, IL). A two-sided probability ≤0.05
was considered statistically significant.
Results
A total of 250 patients were included in the present
study, 125 patients with TTS and 125 patients with
anterior STEMI. Of these, CMR data to evaluate LA
function were available in 249 patients. One TTS patient
was excluded from the analysis because of insufficient
image quality. Active and passive EF could not be deter-
mined in 18 patients due to atrial fibrillation (n = 8 in
the TTS group, n = 10 in the STEMI group). The timefrom initial presentation to CMR imaging was 2 days
(IQR 2–3) in the TTS cohort and 3 days (IQR 2–3.5) in
the STEMI population (p = 0.02).
Baseline characteristics
The baseline clinical characteristics are summarized
in Table 1. Patients with TTS were significantly older
(p < 0.01), more frequently female (p < 0.01), and had
a higher prevalence of hypertension (p = 0.02). Smoking
was more prevalent in STEMI patients (p < 0.01).
LA size and function in TTS versus anterior STEMI
The results of CMR are illustrated in Table 2. While
LA size was fairly similar in both groups considerable
differences were determined regarding LA function.
Patients with TTS demonstrated a significantly lower
total LA-EF [44% (IQR 34–53%) versus 51% (IQR 42–
56%); p < 0.01], passive LA-EF [21% (IQR 14–30%) ver-
sus 24% (IQR 20–29%); p = 0.03], and active LA-EF
[29% (IQR 20–38%) versus 35% (28–42%); p < 0.01]
compared to anterior STEMI patients.
LA function in TTS
A detailed analysis of LA function in TTS patients did
not reveal significant differences between patients
with typical apical ballooning and those with atypical
ballooning patterns (Table 3). However, we observed a
correlation between the LV and the LA function (r =
0.41, p < 0.01; Fig. 2). Therefore, we compared LA
function between TTS patients with ongoing LV dys-
function and patients with already recovered systolic
function (LV ejection fraction >55%). The results ex-
hibited a reduced total and passive LA-EF among






Age (years) 72 (61–78) 62 (51–72) <0.01
Female sex 115/125 (92) 36/125 (29) <0.01
Cardiovascular risk factors
Hypertension 104/125 (83) 88/125 (70) 0.02
Diabetes mellitus 31/125 (25) 28/125 (22) 0.66
Hypercholesterolemia 26/125 (21) 40/125 (32) 0.06
Current smoking 20/125 (16) 46/109 (42) <0.01
Killip-class 3 or 4 on admission 6/125 (5) 4/125 (3) 0.52
Stressful event 84/125 (67) -
Emotional 32/125 (26) -
Physical 52/125 (42) -
Ballooning pattern
Apical 83/125 (66) -
Midventricular 40/125 (32) -
Basal 2/125 (2) -
Number of diseased vessels
1 - 75/125 (60)
2 - 37/125 (30)
3 - 13/125 (10)
TIMI flow grade 0 or 1 before PCI - 77/125 (62)
TIMI flow grade 0 or 1 after PCI - 5/125 (4)
Door-to-balloon time (minutes) - 27 (21–33)
Pain-to-balloon time (minutes) - 220 (130–350)




Values are n/N (%) or median (IQR)
LV left ventricular, PCI percutaneous coronary intervention, STEMI ST-segment
elevation myocardial infarction, TIMI Thrombolysis In Myocardial Infarction, TTS
Takotsubo syndrome
aAssessed with transthoracic echocardiography
P-values in bold type indicate a significant difference between groups






LA area 2-chamber view (cm2)
Ventricular end-systole 21 (18–24) 22 (19–25) 0.03
Ventricular end-diastole 14 (12–19) 14 (12–18) 0.78
LA area 4-chamber view (cm2)
Ventricular end-systole 23 (20–28) 23 (20–27) 0.90
Ventricular end-diastole 16 (12–20) 15 (12–19) 0.26
LA volume biplane (ml)
Ventricular end-systole 72 (55–93) 74 (61–93) 0.36
Immediately before atrial
contractiona
56 (39–70) 55 (46–68) 0.71
Ventricular end-diastole 38 (25–58) 38 (30–49) 0.67
LA function (%)
Total EF (global function;
reservoir)
44 (34–53) 51 (42–56) <0.01
Passive EF (conduit)a 21 (14–30) 24 (20–29) 0.03
Active EF (booster pump)a 29 (20–38) 35 (28–42) <0.01
Values are median (IQR)
EF emptying fraction, LA left atrial, TTS Takotsubo syndrome, STEMI ST-
segment elevation myocardial infarction
aPatients with atrial fibrillation during CMR imaging (n = 8 in the TTS group
and n = 10 in the STEMI group) were excluded from this analysis
P-values in bold type indicate a significant difference between groups
Table 3 Left atrial function in Takotsubo syndrome patients








42 (33–51) 49 (36–56) 0.14
Passive LA-EF (conduit)a 19 (14–29) 23 (15–31) 0.30
Active LA-EF (booster
pump)a
29 (20–38) 30 (21–38) 0.59
Values are median (IQR)
EF emptying fraction, LA left atrial
aPatients with atrial fibrillation during CMR imaging (n = 8) were excluded from
this analysis, resulting in 74 patients with typical ballooning and 42 patients
with an atypical ballooning pattern
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active LA-EF did not differ significantly (Table 4).
In 20 TTS patients follow-up CMR was performed
in median 3.3 months (IQR 3–5 months) after the
initial event. Among these patients, the total LA-EF
improved from 42% (IQR 29–48%) at the acute stage
to 51% (IQR 47–60%) at follow-up (p < 0.01). Simi-
larly, active LA-EF [29% (IQR 22–34%) versus 37%
(IQR 32–39%); p < 0.01] and passive LA-EF [21%
(IQR 14–27%) versus 25% (IQR 19–31%); p = 0.02]
improved significantly. Figure 3 illustrates that 18 of
20 patients (90%) demonstrated an increased total
LA-EF at follow-up while a slight drop was observed
in 2 patients despite recovery of LV function.Discussion
The present study is the first that systematically investigated
LA function and performance during the acute/subacute
phase of TTS by CMR. Compared to a control group
consisting of patients with anterior STEMI, TTS patients
demonstrated a significantly lower total LA-EF with a
deterioration of both the passive and the active phase of LA
function. Furthermore, a detailed analysis of the TTS popu-
lation revealed a superior LA performance in patients with
already normalized LV function and a significant improve-
ment of LA function was observed in a subgroup of patients
with follow-up CMR examinations several months after the
acute phase. These data indicate recovery of LA function in
TTS patients similar to the LV contraction abnormalities.
Fig. 2 Correlation of left atrial and left ventricular function among
Takotsubo syndrome patients. A significant correlation was observed
between LA and LV function among patients with TTS
Fig. 3 Improvement of total left atrial emptying fraction in patients
with Takotsubo syndrome. Shown is the total LA-EF during the
acute/subacute phase as well as at follow-up in 20 patients with TTS.
Each line represents an individual patient. The figure shows a
significant improvement or constantly preserved LA function in 18
patients (black lines) while a slight deterioration was observed in two
patients (red lines) despite recovery of LV function (ejection fraction
53 and 68%, respectively). *Patient with permanent atrial fibrillation.
LA = left atrial; EF = emptying fraction
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The left atrium serves multiple functions acting as a
reservoir for pulmonary venous return and as an active
contracting chamber that augments ventricular filling
[1]. Thus, the left atrium significantly influences cardio-
vascular performance and dilates in response to either
chronic volume or pressure overload. Structural and
functional abnormalities of the left atrium have been
reported in various cardiovascular diseases. Enlargement
of the left atrium is common in patients with atrial fib-
rillation and might represent an important risk factor for
the development of this arrhythmia [18, 19]. Moreover,
the booster pump function is lost during atrial fibrilla-
tion, and the reservoir and conduit functions are also
impaired [2, 20]. Elevated LV diastolic pressure in pa-
tients with heart failure leads to an increased relative
contribution of active LA contraction to LV filling while
the passive conduit function decreases [21]. A potential
causative role of LA dysfunction in heart failure with
preserved LV ejection fraction has been suggestedTable 4 Left atrial function in Takotsubo syndrome patients
with impaired and already recovered left ventricular function
Variable LV ejection fraction
<55% (n = 95)
LV ejection fraction




42 (30–52) 51 (42–59) <0.01
Passive LA-EF
(conduit)a
19 (14–29) 25 (20–35) <0.01
Active LA-EF
(booster pump)a
28 (16–38) 30 (24–39) 0.12
Values are median (IQR)
EF emptying fraction, LA left atrial, LV left ventricular
aPatients with atrial fibrillation during CMR imaging (n = 8) were excluded from
this analysis, resulting in 89 patients with reduced and 27 patients with
recovered LV ejection fraction
P-values in bold type indicate a significant difference between groupsrecently [22]. Furthermore, LA size and function have
been evaluated in several cohorts with ischemic or
valvular heart disease as well as in patients with cardio-
myopathies [1]. In addition to the available data, the
present study for the first time revealed an impaired LA
function in patients with TTS, which was significantly
lower compared to a control population with anterior
STEMI. The observed values in TTS patients are in a
similar range as previously reported in patients with heart
failure or chronic hypertension [4, 23, 24]. However, inter-
study comparisons seem difficult considering the different
methods of assessing LA parameters. Moreover, our study
provides some evidence that LA performance in TTS pa-
tients recovers during follow-up similar to LV function.
Whereas most patients in the sub-population with serial
CMR scans demonstrated an increase in total LA-EF at
follow-up, a slight decrease was observed in two patients
despite normalization of LV ejection fraction. However,
both patients had a long-term history of hypertension
with LV hypertrophy which may also impact LA function.
Moreover, delayed recovery of LV function up to
12 months after the initial event has been reported in TTS
and might apply to the left atrium as well [25]. Further
evidence regarding normalization of LA dysfunction in
TTS is provided by a small trial in 16 patients which
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acute phase of TTS whereas active emptying was in-
creased [9]. At follow-up, complete normalization of LA
emptying volumes was observed.
Reasons for LA impairment in TTS
Patients with TTS exhibit markedly reduced LV ejection
fractions due to pronounced wall motion abnormalities
which can be accompanied by basal hyperdynamic
contraction and obstruction of the LV outflow tract. Con-
sequently, severe LV diastolic dysfunction and substan-
tially increased LV filling pressures have been reported in
TTS patients [26]. Since LA function is closely related to
LV diastolic parameters, a secondary impairment of LA
performance due to an increased LV end-diastolic pres-
sure seems reasonable. Supporting this theory, our TTS
population showed a severely impaired passive LA-EF
while the booster-pump function was only slightly re-
duced compared to previously reported data in healthy in-
dividuals [10]. Similarly, Ahtarovski et al. suggested that
the high active LA contribution might have partly com-
pensated the impaired passive LA function in their cohort
[9]. However, an increased active LA-EF was not observed
in our study. Apart from the theory of a secondarily im-
paired LA function, causative mechanisms directly affect-
ing LA performance cannot be excluded in the absence of
a sufficient pathophysiological concept for the develop-
ment of TTS. Increasing evidence suggests that enhanced
sympathetic activity and catecholamine excess might play
a major role [27]. It is well known that neuroendocrine
factors (e.g. a sustained activation of the angiotensin-
aldosterone system, increases in atrial or brain natriuretic
peptide) can promote LA remodeling and influence LA
function although these mechanisms appear relevant in
chronic diseases rather than in acute conditions as in TTS
[28]. However, a direct effect of TTS on the left atrium
cannot be supported by our data and remains to be
proven in future trials.
Limitations
The study population consisted of a large cohort of
consecutive TTS patients. However, several patients with
a severe course of the disease, particularly those with car-
diogenic shock, could not undergo CMR. Therefore, the
results may not be exactly applicable to these patients.
Moreover, the prognostic impact of an impaired LA func-
tion in TTS patients could not be determined due to a
low number of events during follow-up which does not re-
flect the actual outcome in TTS. Assessment of LA func-
tion was performed by using volumetric indexes only.
Deformation analysis might have provided additional in-
sights. Although CMR images were analyzed by blinded
personnel, the investigators might have presumed the
diagnosis in some cases based on the LV contractionpattern. Furthermore, the majority of TTS patients had a
history of chronic hypertension which might have had a
long-term impact on LA function. Data regarding LA pa-
rameters before the TTS event were not available. Differ-
ences regarding baseline characteristics, particularly age,
sex and chronic hypertension, might have influenced the
comparison between TTS and STEMI patients. Moreover,
the time from presentation to CMR imaging differed be-
tween groups and might have influenced LA function. Fi-
nally, recovery of LA performance was evaluated in a
small sub-population of patients with follow-up CMR data
and a comparison between patients with still impaired and
already recovered LV function. Therefore, the aspect of
LA recovery needs further attention in future trials.
Conclusions
In the present study, TTS was associated with a signifi-
cantly lower LA-EF compared to anterior STEMI
patients with a deterioration of both the passive and the
active phase of LA function. However, our data indicate
that LA performance recovers during follow-up similar
to the LV contraction abnormalities. Consequently, tran-
sient LA dysfunction seems to be an additional feature
of TTS together with the distinct impairment of LV and/
or right ventricular function.
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